Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: A Phase III Confirmatory Study of K-877 Extended Release Tablet [Phase 3]
A Phase III confirmatory study of K-877 Extended Release Tablet (pemafibrate) for dyslipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease [Phase 4]
A Phase 4 clinical trial evaluated intensive blood pressure and LDL lowering in patients with type 2 diabetes and coronary artery disease; t…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Effects of Yogurt With Spirulina on Cardiometabolic Risk Markers [NA]
A completed clinical trial from the Agricultural University of Athens evaluated the effects of spirulina-enriched yogurt on cardiometabolic …
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating umbilical cord-derived mesenchymal stem cells for aging-related low-grade inflammation; currently not re…
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women [Phase 2, Phase 3]
A clinical trial is evaluating a phytoestrogen extract from Pueraria mirifica for improving serum lipid parameters in postmenopausal women, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Dyslipidemia and Diabetic Retinopathy
A completed clinical trial investigating dyslipidemia and diabetic retinopathy has posted results as of May 21, 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes [Phase 4]
A Phase 4 trial comparing Xuezhikang versus atorvastatin on glucose metabolism in patients with dyslipidemia and prediabetes has completed.
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Cottonseed Oil Dose Response [NA]
A clinical trial is investigating the dose response of cottonseed oil for dyslipidemia and overweight/obesity, and it is currently recruitin…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Comparison of Dyslipidemia Among Diabetics Versus Non Diabetics in Haemodialysis Patients
A clinical trial is planned to compare dyslipidemia in diabetic versus non-diabetic patients on hemodialysis; recruitment has not started ye…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia [Phase 4]
Phase 4 clinical trial update of choline fenofibrate for carotid atherosclerosis in patients with Type 2 diabetes mellitus and combined dysl…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia [Phase 4]
Phase 4 trial update on Atmeg (atorvastatin and omega-3) for carotid atherosclerosis in adults with type 2 diabetes mellitus and dyslipidemi…
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) [Phase 4]
EMERALD is a Phase 4 trial evaluating emergency medicine cardiovascular risk assessment for lipid disorders; the study has completed and res…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension [Phase 3]
Phase 3 trial evaluating efficacy and safety of a drug in patients with dyslipidemia and hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Study of A3309 in Patients With Dyslipidemia [Phase 2]
Phase 2 clinical trial update for A3309 in patients with dyslipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events
A completed clinical trial update on preventing cardiovascular events in patients with high to very high risk dyslipidemia; results posted i…
-
FDA approval · 2024-01-16FDA Approved: SIMVASTATIN — Supplemental Application (Biocon Pharma Inc,)
FDA approved Biocon Pharma's supplemental application for simvastatin (ANDA078034), approving a generic simvastatin product filing.
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR [Phase 2]
Phase 2 trial comparing extended-release K-877-ER to immediate-release K-877-IR in dyslipidemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Suvaro®OD Tablet in patients with dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin [Phase 3]
Phase 3 trial update evaluating efficacy and safety of valsartan alone and in combination with simvastatin for hypertension and hypercholest…
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Look AHEAD: Action for Health in Diabetes [NA]
Clinical trial update for Look AHEAD study (diabetes and cardiovascular risk factors) with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of DW1125 and DW1125A for hypercholesterolemia and dyslipidemia has been complet…
-
FDA approval · 2023-07-20FDA Approved: ZETIA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Zetia (ezetimibe) submitted by Organon LLC.
-
FDA approval · 2023-07-19FDA Approved: FENOFIBRIC ACID — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Fenofibric Acid by Micro Labs Limited.
-
FDA approval · 2023-06-21FDA Approved: FENOFIBRIC ACID — Supplemental Application (Leading Pharma, LLC)
FDA approved a supplemental application for fenofibric acid submitted by Leading Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) [Phase 3]
Phase 3 trial update for metformin/atorvastatin combination therapy in adults with Type 2 diabetes and dyslipidemia.